| Authors: |
Zhang Y; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA., Liu Z; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA., Hirschi M; Medicine Design, Pfizer Research and Development, Pfizer, Inc., La Jolla, CA, USA., Brodsky O; Medicine Design, Pfizer Research and Development, Pfizer, Inc., La Jolla, CA, USA., Johnson E; Medicine Design, Pfizer Research and Development, Pfizer, Inc., La Jolla, CA, USA., Won SJ; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA., Nagata A; Medicine Design, Pfizer Research and Development, Pfizer, Inc., La Jolla, CA, USA., Bezwada D; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA., Petroski MD; Oncology Research and Development, Pfizer, Inc., La Jolla, CA, USA., Majmudar JD; Discovery Sciences, Pfizer Research and Development, Pfizer, Inc., Cambridge, MA, USA., Niessen S; Oncology Research and Development, Pfizer, Inc., La Jolla, CA, USA.; Belharra Therapeutics, San Diego, CA, USA., VanArsdale T; Oncology Research and Development, Pfizer, Inc., La Jolla, CA, USA., Gilbert AM; Discovery Sciences, Pfizer Research and Development, Pfizer, Inc., Groton, CT, USA., Hayward MM; Discovery Sciences, Pfizer Research and Development, Pfizer, Inc., Groton, CT, USA.; Magnet Biomedicine, Boston, MA, USA., Stewart AE; Medicine Design, Pfizer Research and Development, Pfizer, Inc., La Jolla, CA, USA., Nager AR; Oncology Research and Development, Pfizer, Inc., La Jolla, CA, USA., Melillo B; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA., Cravatt BF; Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA. cravatt@scripps.edu. |